Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.270
+0.010 (0.79%)
At close: Oct 28, 2025, 4:00 PM EDT
1.260
-0.010 (-0.79%)
After-hours: Oct 28, 2025, 7:46 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $165.92 million as of October 28, 2025. Its market cap has increased by 292.08% in one year.
Market Cap
165.92M
Enterprise Value
161.21M
1-Year Change
292.08%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $165.92M, a decrease of -67.73%. That is a compound annual growth rate of -24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 164.61M | 262.64% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |